Rompag 25 mg: Managing Low Platelet Counts in Chronic Hepatitis C (Health & Beauty - Health Services)
CANetAds > Health & Beauty > Health Services
Item ID 4094358 in Category: Health & Beauty - Health Services
Rompag 25 mg: Managing Low Platelet Counts in Chronic Hepatitis C | |
Eltrombopag, the active ingredient in Rompag 25 mg, is a medication primarily used to treat thrombocytopenia (low platelet count). While it is also used for chronic immune thrombocytopenia (ITP) and severe aplastic anemia (SAA), Rompag 25 mg plays a crucial role in managing low platelet counts specifically in patients with chronic hepatitis C virus (HCV) infections. Eltrombopag functions as a thrombopoietin receptor agonist. This means it stimulates the production of megakaryocytes, which are large cells in the bone marrow responsible for producing platelets. By increasing the number of these megakaryocytes, Eltrombopag effectively boosts platelet production, thereby reducing the risk of bleeding complications that can arise from low platelet counts in HCV patients. For more in-depth information about Rompag 25 mg and its uses, including its role in managing thrombocytopenia associated with Hepatitis C, please visit the Hetero Healthcare website: https://www.heterohealthcare.com/rompag-25-mg-tablets | |
| Target Prov.: All Provinces Target City : Madhapur,Telengana Last Update : May 10, 2025 8:55 AM Number of Views: 8 | Item Owner : Hetero Healthcare Contact Email: Contact Phone: (None) |
| Friendly reminder: Click here to read some tips. | |
CANetAds > Health & Beauty > Health Services
© 2025 CANetAds.com
USNetAds.com | GetJob.us | UKAdsList.com | AUNetAds.com | INNetAds.com | CNNetAds.com | Hot-Web-Ads.com | USAOnlineClassifieds.com
2025-05-10 (0.392 sec)